{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:44:43Z","timestamp":1790804683305,"version":"4.1.0"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T00:00:00Z","timestamp":1581292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000056","name":"Bench to Bedside Award","doi-asserted-by":"publisher","award":["10-2013\/Office of Rare Disease\/NINR"],"award-info":[{"award-number":["10-2013\/Office of Rare Disease\/NINR"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000056","name":"National Institute of Nursing Research","doi-asserted-by":"publisher","award":["Intramural Program"],"award-info":[{"award-number":["Intramural Program"]}],"id":[{"id":"10.13039\/100000056","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["Intramural Program"],"award-info":[{"award-number":["Intramural Program"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000098","name":"NIH Clinical Center","doi-asserted-by":"publisher","award":["Intramural Program"],"award-info":[{"award-number":["Intramural Program"]}],"id":[{"id":"10.13039\/100000098","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Qual Life Res"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s11136-020-02428-2","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T14:03:58Z","timestamp":1581343438000},"page":"1641-1653","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with RYR1-related myopathies pre-post-N-acetylcysteine therapy"],"prefix":"10.1007","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2520-0650","authenticated-orcid":false,"given":"Carlos","family":"Capella-Peris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6133-6574","authenticated-orcid":false,"given":"Mary M.","family":"Cosgrove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4240-8165","authenticated-orcid":false,"given":"Irene C.","family":"Chrismer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"Emile-Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8168-0321","authenticated-orcid":false,"given":"M. Sonia","family":"Razaqyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5951-0983","authenticated-orcid":false,"given":"Paul G.","family":"Wakim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5686-5423","authenticated-orcid":false,"given":"Katherine G.","family":"Meilleur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,2,10]]},"reference":[{"key":"2428_CR1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1524-4733.2009.00609.x","volume-title":"Guidance for industry patient-reported outcome measures: Use in medical product development to support labeling claims","author":"U.S. Food and Drug Administration","year":"2009","unstructured":"U.S. Food and Drug Administration. (2009). Guidance for industry patient-reported outcome measures: Use in medical product development to support labeling claims. Rockville, MD: U.S. Food and Drug Administration. https:\/\/doi.org\/10.1111\/j.1524-4733.2009.00609.x"},{"key":"2428_CR2","volume-title":"Patient-focused drug development: Collecting comprehensive and representative input","author":"U.S. Food and Drug Administration","year":"2018","unstructured":"U.S. Food and Drug Administration. (2018). Patient-focused drug development: Collecting comprehensive and representative input. Rockville, MD: U.S. Food and Drug Administration."},{"key":"2428_CR3","volume-title":"Patient-focused drug development: Methods to identify what is important to patients","author":"U.S. Food and Drug Administration","year":"2019","unstructured":"U.S. Food and Drug Administration. (2019). Patient-focused drug development: Methods to identify what is important to patients. Rockville, MD: U.S. Food and Drug Administration."},{"key":"2428_CR4","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-014-0070-8","volume-title":"Rare diseases: Common issues in drug development. Guidance for industry","author":"U.S. Food and Drug Administration","year":"2019","unstructured":"U.S. Food and Drug Administration. (2019). Rare diseases: Common issues in drug development. Guidance for industry. Rockville, MD: U.S. Food and Drug Administration. https:\/\/doi.org\/10.1186\/s13045-014-0070-8"},{"issue":"1","key":"2428_CR5","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1097\/00012272-198510000-00005","volume":"8","author":"CE Ferrans","year":"1985","unstructured":"Ferrans, C. E., & Powers, M. J. (1985). Quality of life index: Development and psychometric properties. Advances in Nursing Science,8(1), 15\u201324. https:\/\/doi.org\/10.1097\/00012272-198510000-00005.","journal-title":"Advances in Nursing Science"},{"issue":"1","key":"2428_CR6","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s13023-017-0718-x","volume":"12","author":"T Morel","year":"2017","unstructured":"Morel, T., & Cano, S. J. (2017). Measuring what matters to rare disease patients\u2014Reflections on the work by the IRDiRC taskforce on patient-centered outcome measures. Orphanet Journal of Rare Diseases,12(1), 171. https:\/\/doi.org\/10.1186\/s13023-017-0718-x.","journal-title":"Orphanet Journal of Rare Diseases"},{"issue":"4","key":"2428_CR7","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/ana.22510","volume":"70","author":"K Amburgey","year":"2011","unstructured":"Amburgey, K., McNamara, N., Bennett, L. R., McCormick, M. E., Acsadi, G., & Dowling, J. J. (2011). Prevalence of congenital myopathies in a representative pediatric united states population. Annals of Neurology,70(4), 662\u2013665. https:\/\/doi.org\/10.1002\/ana.22510.","journal-title":"Annals of Neurology"},{"key":"2428_CR8","doi-asserted-by":"publisher","first-page":"118","DOI":"10.3389\/fneur.2018.00118","volume":"9","author":"JJ Todd","year":"2018","unstructured":"Todd, J. J., Razaqyar, M. S., Witherspoon, J. W., Lawal, T. A., Mankodi, A., Chrismer, I. C., et al. (2018). Novel variants in individuals with RYR1-related congenital myopathies: Genetic, laboratory, and clinical findings. Frontiers in Neurology,9, 118. https:\/\/doi.org\/10.3389\/fneur.2018.00118.","journal-title":"Frontiers in Neurology"},{"key":"2428_CR9","unstructured":"Todd, J. J., Lawal, T. A., Witherspoon, J. W., Chrismer, I. C., Razaqyar, M. S., Punjabi, M., et al. (2019). A randomized controlled trial of N-acetylcysteine therapy for RYR1-related myopathies. Neurology, in press (under embargo)."},{"issue":"7","key":"2428_CR10","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.nmd.2013.03.008","volume":"23","author":"N Dlamini","year":"2013","unstructured":"Dlamini, N., Voermans, N. C., Lillis, S., Stewart, K., Kamsteeg, E.-J., Drost, G., et al. (2013). Mutations in RYR1 are a common cause of exertional myalgia and rhabdomyolysis. Neuromuscular Disorders,23(7), 540\u2013548. https:\/\/doi.org\/10.1016\/j.nmd.2013.03.008.","journal-title":"Neuromuscular Disorders"},{"issue":"8","key":"2428_CR11","doi-asserted-by":"publisher","first-page":"2024","DOI":"10.1093\/brain\/awm096","volume":"130","author":"H Zhou","year":"2007","unstructured":"Zhou, H., Jungbluth, H., Sewry, C. A., Feng, L., Bertini, E., Bushby, K., et al. (2007). Molecular mechanisms and phenotypic variation in RYR1-related congenital myopathies. Brain,130(8), 2024\u20132036. https:\/\/doi.org\/10.1093\/brain\/awm096.","journal-title":"Brain"},{"issue":"1","key":"2428_CR12","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.nmd.2018.10.006","volume":"29","author":"E van Ruitenbeek","year":"2019","unstructured":"van Ruitenbeek, E., Custers, J. A. E., Verhaak, C., Snoeck, M., Erasmus, C. E., Kamsteeg, E. J., et al. (2019). Functional impairments, fatigue and quality of life in RYR1-related myopathies: A questionnaire study. Neuromuscular Disorders,29(1), 30\u201338. https:\/\/doi.org\/10.1016\/j.nmd.2018.10.006.","journal-title":"Neuromuscular Disorders"},{"issue":"4","key":"2428_CR13","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1093\/brain\/aws036","volume":"135","author":"JJ Dowling","year":"2012","unstructured":"Dowling, J. J., Arbogast, S., Hur, J., Nelson, D. D., McEvoy, A., Waugh, T., et al. (2012). Oxidative stress and successful antioxidant treatment in models of RYR1-related myopathy. Brain,135(4), 1115\u20131127. https:\/\/doi.org\/10.1093\/brain\/aws036.","journal-title":"Brain"},{"issue":"1","key":"2428_CR14","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cell.2008.02.042","volume":"133","author":"WJ Durham","year":"2008","unstructured":"Durham, W. J., Aracena-Parks, P., Long, C., Rossi, A. E., Goonasekera, S. A., Boncompagni, S., et al. (2008). RyR1 S-nitrosylation underlies environmental heat stroke and sudden death in Y522S RyR1 knockin mice. Cell,133(1), 53\u201365. https:\/\/doi.org\/10.1016\/j.cell.2008.02.042.","journal-title":"Cell"},{"issue":"4","key":"2428_CR15","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.outlook.2015.03.001","volume":"63","author":"AK Cashion","year":"2015","unstructured":"Cashion, A. K., & Grady, P. A. (2015). The National Institutes of Health\/National Institutes of Nursing Research intramural research program and the development of the National Institutes of Health Symptom Science Model. Nursing Outlook,63(4), 484\u2013487. https:\/\/doi.org\/10.1016\/j.outlook.2015.03.001.","journal-title":"Nursing Outlook"},{"key":"2428_CR16","volume-title":"Designing and conducting mixed methods research","author":"JW Creswell","year":"2007","unstructured":"Creswell, J. W., & Plano Clark, V. L. (2007). Designing and conducting mixed methods research. Thousand Oaks, CA: Sage Publications."},{"issue":"3","key":"2428_CR17","doi-asserted-by":"publisher","first-page":"255","DOI":"10.3102\/01623737011003255","volume":"11","author":"JC Greene","year":"1989","unstructured":"Greene, J. C., Caracelli, V. J., & Graham, W. F. (1989). Toward a conceptual framework for mixed-method evaluation designs. Educational Evaluation and Policy Analysis,11(3), 255\u2013274. https:\/\/doi.org\/10.3102\/01623737011003255.","journal-title":"Educational Evaluation and Policy Analysis"},{"issue":"1","key":"2428_CR18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1007\/s10897-014-9752-1","volume":"24","author":"A\u00d8 Geirdal","year":"2015","unstructured":"Geirdal, A. \u00d8., Lund-Petersen, I., & Heiberg, A. (2015). Understanding the experience of Myotonic Dystrophy. Mixed method study. Journal of Genetic Counseling,24(1), 169\u2013178. https:\/\/doi.org\/10.1007\/s10897-014-9752-1.","journal-title":"Journal of Genetic Counseling"},{"issue":"7","key":"2428_CR19","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1177\/0883073813484804","volume":"29","author":"NE Johnson","year":"2014","unstructured":"Johnson, N. E., Luebbe, E., Eastwood, E., Chin, N., Moxley, R. T., & Heatwole, C. R. (2014). The impact of congenital and childhood myotonic dystrophy on quality of life: A qualitative study of associated symptoms. Journal of Child Neurology,29(7), 983\u2013986. https:\/\/doi.org\/10.1177\/0883073813484804.","journal-title":"Journal of Child Neurology"},{"issue":"3","key":"2428_CR20","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.nmd.2019.01.010","volume":"29","author":"N Vorster","year":"2019","unstructured":"Vorster, N., Evans, K., Murphy, N., Kava, M., Cairns, A., Clarke, D., et al. (2019). Powered standing wheelchairs promote independence, health and community involvement in adolescents with Duchenne muscular dystrophy. Neuromuscular Disorders,29(3), 221\u2013230. https:\/\/doi.org\/10.1016\/j.nmd.2019.01.010.","journal-title":"Neuromuscular Disorders"},{"key":"2428_CR21","volume-title":"An introduction to qualitative research","author":"U Flick","year":"2014","unstructured":"Flick, U. (2014). An introduction to qualitative research (5th ed.). Thousand Oaks, CA: Sage Publications.","edition":"5"},{"issue":"4","key":"2428_CR22","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","volume":"52","author":"B Saunders","year":"2018","unstructured":"Saunders, B., Sim, J., Kingstone, T., Baker, S., Waterfield, J., Bartlam, B., et al. (2018). Saturation in qualitative research: Exploring its conceptualization and operationalization. Quality & Quantity,52(4), 1893\u20131907. https:\/\/doi.org\/10.1007\/s11135-017-0574-8.","journal-title":"Quality & Quantity"},{"issue":"20","key":"2428_CR23","doi-asserted-by":"publisher","first-page":"e1928","DOI":"10.1212\/WNL.0000000000006497","volume":"91","author":"K LaFaver","year":"2018","unstructured":"LaFaver, K., Miyasaki, J. M., Keran, C. M., Rheaume, C., Gulya, L., Levin, K. H., et al. (2018). Age and sex differences in burnout, career satisfaction, and well-being in US neurologists. Neurology,91(20), e1928\u2013e1941. https:\/\/doi.org\/10.1212\/WNL.0000000000006497.","journal-title":"Neurology"},{"issue":"6","key":"2428_CR24","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/mus.23529","volume":"46","author":"NE Johnson","year":"2012","unstructured":"Johnson, N. E., Quinn, C., Eastwood, E., Tawil, R., & Heatwole, C. R. (2012). Patient-identified disease burden in facioscapulohumeral muscular dystrophy. Muscle & Nerve,46(6), 948\u2013950. https:\/\/doi.org\/10.1002\/mus.23529.","journal-title":"Muscle & Nerve"},{"key":"2428_CR25","volume-title":"Research Design. Qualitative, quantitative and mixed methods approaches","author":"JW Creswell","year":"2014","unstructured":"Creswell, J. W. (2014). Research Design. Qualitative, quantitative and mixed methods approaches (4th ed.). London, UK: Sage Publications.","edition":"4"},{"issue":"16","key":"2428_CR26","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1212\/WNL.0000000000004526","volume":"89","author":"JM Miyasaki","year":"2017","unstructured":"Miyasaki, J. M., Rheaume, C., Gulya, L., Ellenstein, A., Schwarz, H. B., Vidic, T. R., et al. (2017). Qualitative study of burnout, career satisfaction, and well-being among US neurologists in 2016. Neurology,89(16), 1730\u20131738. https:\/\/doi.org\/10.1212\/WNL.0000000000004526.","journal-title":"Neurology"},{"issue":"11","key":"2428_CR27","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1016\/j.jclinepi.2010.04.011","volume":"63","author":"D Cella","year":"2010","unstructured":"Cella, D., Riley, W., Stone, A., Rothrock, N., Reeve, B., Yount, S., et al. (2010). The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005\u20132008. Journal of Clinical Epidemiology,63(11), 1179\u20131194. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.011.","journal-title":"Journal of Clinical Epidemiology"},{"issue":"10","key":"2428_CR28","doi-asserted-by":"publisher","first-page":"S28","DOI":"10.1016\/j.apmr.2011.01.025","volume":"92","author":"D Cella","year":"2011","unstructured":"Cella, D., Nowinski, C., Peterman, A., Victorson, D., Miller, D., Lai, J.-S., et al. (2011). The neurology quality-of-life measurement initiative. Archives of Physical Medicine and Rehabilitation,92(10), S28\u2013S36. https:\/\/doi.org\/10.1016\/j.apmr.2011.01.025.","journal-title":"Archives of Physical Medicine and Rehabilitation"},{"issue":"11","key":"2428_CR29","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.nmd.2018.09.003","volume":"28","author":"EEDH Abel","year":"2018","unstructured":"Abel, E. E. D. H., Cup, E. H. C., Lanser, A., Leclercq, W. K. G., Raaphorst, J., Padberg, G. W., et al. (2018). Experiences with bariatric surgery in patients with facioscapulohumeral dystrophy and myotonic dystrophy type 1: A qualitative study. Neuromuscular Disorders,28(11), 938\u2013946. https:\/\/doi.org\/10.1016\/j.nmd.2018.09.003.","journal-title":"Neuromuscular Disorders"},{"issue":"2","key":"2428_CR30","doi-asserted-by":"publisher","first-page":"E3","DOI":"10.1097\/JNN.0b013e31828291a6","volume":"45","author":"YT Chen","year":"2013","unstructured":"Chen, Y. T., Shih, F. J., Hayter, M., Hou, C. C., & Yeh, J. H. (2013). Experiences of living with myasthenia gravis: A qualitative study with taiwanese people. Journal of Neuroscience Nursing,45(2), E3\u2013E10. https:\/\/doi.org\/10.1097\/JNN.0b013e31828291a6.","journal-title":"Journal of Neuroscience Nursing"},{"issue":"5","key":"2428_CR31","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/j.cpr.2010.03.003","volume":"30","author":"DM Davydov","year":"2010","unstructured":"Davydov, D. M., Stewart, R., Ritchie, K., & Chaudieu, I. (2010). Resilience and mental health. Clinical Psychology Review,30(5), 479\u2013495. https:\/\/doi.org\/10.1016\/j.cpr.2010.03.003.","journal-title":"Clinical Psychology Review"},{"issue":"6","key":"2428_CR32","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1111\/j.1467-6494.2009.00599.x","volume":"77","author":"A Steptoe","year":"2009","unstructured":"Steptoe, A., Dockray, S., & Wardle, J. (2009). Positive affect and psychobiological processes relevant to health. Journal of Personality,77(6), 1747\u20131776. https:\/\/doi.org\/10.1111\/j.1467-6494.2009.00599.x.","journal-title":"Journal of Personality"},{"issue":"12","key":"2428_CR33","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1212\/01.wnl.0000188870.37076.f2","volume":"65","author":"H Jungbluth","year":"2005","unstructured":"Jungbluth, H., Zhou, H., Hartley, L., Halliger-Keller, B., Messina, S., Longman, C., et al. (2005). Minicore myopathy with ophthalmoplegia caused by mutations in the ryanodine receptor type 1 gene. Neurology,65(12), 1930\u20131935. https:\/\/doi.org\/10.1212\/01.wnl.0000188870.37076.f2.","journal-title":"Neurology"},{"issue":"9","key":"2428_CR34","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1001\/archneurol.2011.188","volume":"68","author":"A Klein","year":"2011","unstructured":"Klein, A., Jungbluth, H., Clement, E., Lillis, S., Abbs, S., Munot, P., et al. (2011). Muscle magnetic resonance imaging in congenital myopathies due to ryanodine receptor type 1 gene mutations. Archives of Neurology,68(9), 1171\u20131179. https:\/\/doi.org\/10.1001\/archneurol.2011.188.","journal-title":"Archives of Neurology"},{"issue":"4","key":"2428_CR35","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1002\/mus.26420","volume":"59","author":"KA Hagerman","year":"2019","unstructured":"Hagerman, K. A., Howe, S. J., & Heatwole, C. E. (2019). The myotonic dystrophy experience: A North American cross-sectional study. Muscle & Nerve,59(4), 457\u2013464. https:\/\/doi.org\/10.1002\/mus.26420.","journal-title":"Muscle & Nerve"},{"issue":"9","key":"2428_CR36","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s00415-010-5549-9","volume":"257","author":"Y Winter","year":"2010","unstructured":"Winter, Y., Schepelmann, K., Spottke, A. E., Claus, D., Grothe, C., Schr\u00f6der, R., et al. (2010). Health-Related Quality of Life in ALS, myasthenia gravis and facioscapulohumeral muscular dystrophy. Journal of Neurology,257(9), 1473\u20131481. https:\/\/doi.org\/10.1007\/s00415-010-5549-9.","journal-title":"Journal of Neurology"},{"issue":"1","key":"2428_CR37","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3109\/01942630903294687","volume":"30","author":"P Bray","year":"2010","unstructured":"Bray, P., Bundy, A. C., Ryan, M. M., & North, K. N. (2010). Feasibility of a computerized method to measure quality of \u201ceveryday\u201d life in children with neuromuscular disorders. Physical & Occupational Therapy In Pediatrics,30(1), 43\u201353. https:\/\/doi.org\/10.3109\/01942630903294687.","journal-title":"Physical & Occupational Therapy In Pediatrics"},{"issue":"5","key":"2428_CR38","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1016\/S0960-8966(99)00006-1","volume":"9","author":"N Miladi","year":"1999","unstructured":"Miladi, N., Bourguignon, J.-P., & Hentati, F. (1999). Cognitive and psychological profile of a Tunisian population of limb girdle muscular dystrophy. Neuromuscular Disorders,9(5), 352\u2013354. https:\/\/doi.org\/10.1016\/S0960-8966(99)00006-1.","journal-title":"Neuromuscular Disorders"},{"issue":"7","key":"2428_CR39","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s40273-016-0389-9","volume":"34","author":"M Karimi","year":"2016","unstructured":"Karimi, M., & Brazier, J. (2016). Health, Health-Related Quality of Life, and quality of life: What is the difference? PharmacoEconomics,34(7), 645\u2013649. https:\/\/doi.org\/10.1007\/s40273-016-0389-9.","journal-title":"PharmacoEconomics"},{"issue":"2","key":"2428_CR40","doi-asserted-by":"publisher","first-page":"e140","DOI":"10.1212\/NXG.0000000000000140","volume":"3","author":"N Witting","year":"2017","unstructured":"Witting, N., Werlauff, U., Duno, M., & Vissing, J. (2017). Phenotypes, genotypes, and prevalence of congenital myopathies older than 5 years in Denmark. Neurology Genetics,3(2), e140. https:\/\/doi.org\/10.1212\/NXG.0000000000000140.","journal-title":"Neurology Genetics"},{"issue":"6","key":"2428_CR41","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.nmd.2011.03.006","volume":"21","author":"JJ Dowling","year":"2011","unstructured":"Dowling, J. J., Lillis, S., Amburgey, K., Zhou, H., Al-Sarraj, S., Buk, S. J. A., et al. (2011). King-Denborough syndrome with and without mutations in the skeletal muscle ryanodine receptor (RYR1) gene. Neuromuscular Disorders,21(6), 420\u2013427. https:\/\/doi.org\/10.1016\/j.nmd.2011.03.006.","journal-title":"Neuromuscular Disorders"},{"issue":"2","key":"2428_CR42","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1212\/WNL.59.2.284","volume":"59","author":"H Jungbluth","year":"2002","unstructured":"Jungbluth, H., M\u00fcller, C. R., Halliger-Keller, B., Brockington, M., Brown, S. C., Feng, L., et al. (2002). Autosomal recessive inheritance of RYR1 mutations in a congenital myopathy with cores. Neurology,59(2), 284\u2013287. https:\/\/doi.org\/10.1212\/WNL.59.2.284.","journal-title":"Neurology"},{"issue":"5","key":"2428_CR43","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.1212\/WNL.0000000000004894","volume":"90","author":"E Matthews","year":"2018","unstructured":"Matthews, E., Neuwirth, C., Jaffer, F., Scalco, R. S., Fialho, D., Parton, M., et al. (2018). Atypical periodic paralysis and myalgia. Neurology,90(5), e412\u2013e418. https:\/\/doi.org\/10.1212\/WNL.0000000000004894.","journal-title":"Neurology"},{"issue":"11","key":"2428_CR44","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.1212\/WNL.55.11.1689","volume":"55","author":"PC Scacheri","year":"2000","unstructured":"Scacheri, P. C., Hoffman, E. P., Fratkin, J. D., Semino-Mora, C., Senchak, A., Davis, M. R., et al. (2000). A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy. Neurology,55(11), 1689\u20131696. https:\/\/doi.org\/10.1212\/WNL.55.11.1689.","journal-title":"Neurology"},{"issue":"1","key":"2428_CR45","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/ALN.0b013e3181c29504","volume":"112","author":"JF Capacchione","year":"2010","unstructured":"Capacchione, J. F., Sambuughin, N., Bina, S., Mulligan, L. P., Lawson, T. D., & Muldoon, S. M. (2010). Exertional rhabdomyolysis and malignant hyperthermia in a patient with ryanodine receptor type 1 gene, L-type calcium channel \u03b1-1 subunit gene, and calsequestrin-1 gene polymorphisms. Anesthesiology,112(1), 239\u2013244. https:\/\/doi.org\/10.1097\/ALN.0b013e3181c29504.","journal-title":"Anesthesiology"},{"issue":"4","key":"2428_CR46","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1093\/bja\/88.4.508","volume":"88","author":"M Davis","year":"2002","unstructured":"Davis, M., Brown, R., Dickson, A., Horton, H., James, D., Laing, N., et al. (2002). Malignant hyperthermia associated with exercise-induced rhabdomyolysis or congenital abnormalities and a novel RYR1 mutation in New Zealand and Australian pedigrees. British Journal of Anaesthesia,88(4), 508\u2013515. https:\/\/doi.org\/10.1093\/bja\/88.4.508.","journal-title":"British Journal of Anaesthesia"},{"issue":"70","key":"2428_CR47","doi-asserted-by":"publisher","first-page":"70ra14","DOI":"10.1126\/scitranslmed.3001244","volume":"3","author":"U Bingel","year":"2011","unstructured":"Bingel, U., Wanigasekera, V., Wiech, K., Ni Mhuircheartaigh, R., Lee, M. C., Ploner, M., et al. (2011). The effect of treatment expectation on drug efficacy: Imaging the analgesic benefit of the opioid Remifentanil. Science Translational Medicine,3(70), 70ra14. https:\/\/doi.org\/10.1126\/scitranslmed.3001244.","journal-title":"Science Translational Medicine"},{"issue":"8","key":"2428_CR48","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1016\/S0277-9536(98)00411-0","volume":"48","author":"GL Albrecht","year":"1999","unstructured":"Albrecht, G. L., & Devlieger, P. J. (1999). The disability paradox: High quality of life against all odds. Social Science & Medicine,48(8), 977\u2013988. https:\/\/doi.org\/10.1016\/S0277-9536(98)00411-0.","journal-title":"Social Science & Medicine"},{"issue":"1","key":"2428_CR49","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.ejpn.2010.07.003","volume":"15","author":"CM de Oliveira","year":"2011","unstructured":"de Oliveira, C. M., & de Ara\u00fajo, A. P. Q. C. (2011). Self-reported quality of life has no correlation with functional status in children and adolescents with spinal muscular atrophy. European Journal of Paediatric Neurology,15(1), 36\u201339. https:\/\/doi.org\/10.1016\/j.ejpn.2010.07.003.","journal-title":"European Journal of Paediatric Neurology"},{"issue":"5","key":"2428_CR50","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1111\/dmcn.12938","volume":"58","author":"E Landfeldt","year":"2016","unstructured":"Landfeldt, E., Lindgren, P., Bell, C. F., Guglieri, M., Straub, V., Lochm\u00fcller, H., et al. (2016). Health-Related Quality of Life in patients with Duchenne muscular dystrophy: A multinational, cross-sectional study. Developmental Medicine & Child Neurology,58(5), 508\u2013515. https:\/\/doi.org\/10.1111\/dmcn.12938.","journal-title":"Developmental Medicine & Child Neurology"},{"issue":"3","key":"2428_CR51","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1212\/WNL.55.3.388","volume":"55","author":"Z Simmons","year":"2000","unstructured":"Simmons, Z., Bremer, B. A., Robbins, R. A., Walsh, S. M., & Fischer, S. (2000). Quality of life in ALS depends on factors other than strength and physical function. Neurology,55(3), 388\u2013392. https:\/\/doi.org\/10.1212\/WNL.55.3.388.","journal-title":"Neurology"}],"updated-by":[{"DOI":"10.1007\/s11136-020-02486-6","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000}}],"container-title":["Quality of Life Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-020-02428-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11136-020-02428-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11136-020-02428-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,10]],"date-time":"2021-02-10T00:07:11Z","timestamp":1612915631000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11136-020-02428-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,10]]},"references-count":51,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["2428"],"URL":"https:\/\/doi.org\/10.1007\/s11136-020-02428-2","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s11136-020-02486-6","asserted-by":"object"}]},"ISSN":["0962-9343","1573-2649"],"issn-type":[{"value":"0962-9343","type":"print"},{"value":"1573-2649","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,10]]},"assertion":[{"value":"11 January 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 February 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2020","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The article Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with <Emphasis Type=\"Italic\">RYR1<\/Emphasis>-related myopathies pre-post-<Emphasis Type=\"Italic\">N<\/Emphasis>-acetylcysteine therapy, written by Carlos\u00a0Capella-Peris, Mary\u00a0M.\u00a0Cosgrove, Irene\u00a0C.\u00a0Chrismer, Magalie\u00a0Emile-Backer, M.\u00a0Sonia\u00a0Razaqyar, Jefrey\u00a0S.\u00a0Elliott, Anna\u00a0Kuo, Paul\u00a0G.\u00a0Wakim, Katherine\u00a0G.\u00a0Meilleur, was originally published electronically on the publisher\u2019s internet portal (<ExternalRef><RefSource>https:\/\/doi.org\/10.1007\/s11136-020-02428-2<\/RefSource><RefTarget Address=\"10.1007\/s11136-020-02428-2\" TargetType=\"DOI\"\/><\/ExternalRef>) on 10 February 2020 with open access. With the author(s)\u2019 decision to step back from Open Choice, the copyright of the article changed on 1 April 2020 to \u00a9 Springer Nature Switzerland AG, 2020 and the article is forthwith distributed under the terms of copyright.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original article has been corrected.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"Dr. Carlos Capella-Peris, Ms. Mary M. Cosgrove, Ms.\u00a0Irene C. Chrismer, Dr.\u00a0Magalie Emile-Backer, Ms.\u00a0M.\u00a0Sonia Razaqyar, Mr.\u00a0Jeffrey S. Elliott, Ms. Anna Kuo, and Dr.\u00a0Paul G. Wakim have no conflicts of interest. Dr.\u00a0Katherine G. Meilleur has received support from the RYR-1 Foundation, and an NIH Clinical Center Bench to Bedside Award (10-2013\/Office of Rare Disease\/NINR).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}